Efficacy and Safety of Celecoxib in Chinese Patients with Ankylosing Spondylitis: A 6-Week Randomized, Double-Blinded Study with 6-Week Open-Label Extension Treatment

• Main Authors: Feng Huang, MD (Author), Jieruo Gu, MD (Author), Yi Liu, MD (Author), Ping Zhu, MD (Author), Yi Zheng, MD (Author), Jin Fu, MD (Author), Sharon Pan, PhD (Author), Shi Le, MD (Author)
• Format: Book
• Published: Elsevier, 2014-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Nonsteroidal anti-inflammatory drugs are the first-line option for treating ankylosing spondylitis (AS) in China. However, no large-scale controlled trials have been conducted in this ethnic population. Objective: To evaluate the efficacy and safety of 6 weeks' treatment with celeco...